Comparison of the San Francisco Syncope Rule, Canadian Syncope Risk Score and Anatolian Syncope Rule in Patients Presenting to the Emergency Department with Syncope

Basit Öğe Kaydı
dc.contributor.authorSultanoğlu, Hasan
dc.contributor.authorDoğan, Burcu
dc.contributor.authorYazla, Merve
dc.contributor.authorGünsay, Handan
dc.contributor.authorKomut, Seval
dc.contributor.authorDuran, Cemal Yasin
dc.date.accessioned2026-07-01T11:33:51Z
dc.date.available2026-07-01T11:33:51Z
dc.date.issued2026
dc.departmentDüzce Üniversitesi
dc.description.abstractObjectives: Syncope is a common cause of emergency department admissions and poses challenges in patient management due to its broad etiology and risk of short-term adverse events. This study aimed to comparatively evaluate the ability of the San Francisco Syncope Rule, Canadian Syncope Risk Score and Anatolian Syncope Rule to predict short-term (1-week and 1-month) adverse events in patients presenting to the emergency department with syncope. Methods: This multicenter, prospective, observational study included 108 patients who presented to the emergency departments of two tertiary-level hospitals with syncope. Patients aged <18 years, pregnant women, those with non-syncopal causes of transient loss of consciousness, and those requiring hospitalization at presentation were excluded. Patients were contacted by phone on the 7th and 30th days after discharge to assess adverse events, including death, life-threatening arrhythmias, myocardial infarction, aortic dissection, pulmonary embolism, major bleeding, and subarachnoid hemorrhage. Results: The mean age was 45.9±18.9 years, and 57.4% were female. The most common comorbidity was hypertension (34.3%), and vasovagal syncope (47.2%) was the leading etiology. Within 1 week, 8 (7.4%) patients experienced adverse events; none occurred at 1 month. Median scores were 0 for the San Francisco Syncope Rule, 1 for the Anatolian Syncope Rule, and 0 for the Canadian Syncope Risk Score; among those with events: 0.5, 2, 3, respectively. Conclusions: The San Francisco Syncope Rule showed limited early discrimination, the Canadian Syncope Risk Score identified high-risk patients, and the Anatolian Syncope Rule better stratified low–moderate risk groups. Risk scores should complement, not replace, clinical judgment.
dc.identifier.dergipark1802723
dc.identifier.doi10.18621/eurj.1802723
dc.identifier.endpage118
dc.identifier.issn2149-3189
dc.identifier.issue1
dc.identifier.startpage108
dc.identifier.trdizinid1377652
dc.identifier.urihttps://doi.org/10.18621/eurj.1802723
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1377652
dc.identifier.urihttps://hdl.handle.net/20.500.12684/22775
dc.identifier.volume12
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofThe European Research Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR_20260623
dc.subjectAcil Tıp
dc.subjectKalp ve Kalp Damar Sistemi
dc.titleComparison of the San Francisco Syncope Rule, Canadian Syncope Risk Score and Anatolian Syncope Rule in Patients Presenting to the Emergency Department with Syncope
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu